Low frequency ultrasound improves clot-busters:
This article was originally published in Clinica
Low-frequency ultrasound could allow lower doses of thrombolytic drugs to be used in treating the blood clots that cause stroke, according to results presented at Neurosonology 97 by Dr Masahiko Akiyama of Jikei University in Tokyo. In vitro studies carried out by Dr Akiyama revealed that by treating blood clots with ultrasound as well as urokinase, the time taken to dissolve them could be halved.
You may also be interested in...
Office of New Drugs Director Peter Stein said in an interview that a large amount of coronavirus-related work is arriving at the FDA, but so far staff are keeping up.
Akero’s FGF21 analog yields 63%-72% relative hepatic fat reduction in Phase IIa study; the company awaits biopsy data hoping to see a fibrotic benefit. Also, Genfit says COVID-19 pandemic should not significantly delay its Phase III NASH readout.
US Vice President Mike Pence and Medicare administrator Seema Verma want academic and university hospital laboratories to send their de-identified COVID-19 test data results, daily, to the Department of Health and Human Services. Commercial and private labs are exempt from the request, as they already share their coronavirus test results with the government.